サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790205

細胞培養サプリメントの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2033年

Cell Culture Supplements Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.73円
細胞培養サプリメントの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2033年
出版日: 2025年07月29日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞培養サプリメント市場概要

細胞培養サプリメントの世界市場規模は2024年に25億3,000万米ドルと推定され、2033年には71億4,000万米ドルに達すると予測され、2025～2033年のCAGRは12.74%で成長します。この成長の原動力は、バイオ医薬品需要の増加、細胞培養技術の進歩、個別化医療と再生療法への注目の高まりです。

3D細胞培養とオルガノイドモデルの進歩

3D細胞培養システムとオルガノイド技術の採用拡大が、世界の細胞培養サプリメント市場の需要を大きく牽引しています。従来型2D培養とは異なり、3Dモデルは生体内の細胞環境を正確に表現するため、研究者は組織開発、がん転移、薬剤反応などの複雑な生物学的プロセスをよりよく研究することができます。特にオルガノイドは、実際のヒト臓器のアーキテクチャと機能を再現するため、再生医療や疾患モデリングにおいて不可欠なツールとなっています。例えば、2025年7月にScientific Reports誌に発表された研究では、感染症研究のためのオルガノイドベースモデルの進歩について詳述しています。幹細胞に由来するこの三次元細胞培養系は、従来型二次元培養系よりも生理学的に適切なヒト臓器シミュレーションを記載しています。この研究は、創薬を加速し、動物モデルへの依存を減らすオルガノイド技術の可能性を強調しています。このような先進的モデルでは、細胞の分化、生存能力、機能をサポートするために、成長因子、細胞外マトリックスタンパク質、定義された培地成分など、非常に特異的な培養条件と特殊なサプリメントが必要となります。

製薬会社、バイオテクノロジー企業、学術機関は、創薬効率を向上させ、動物実験への依存を減らすために、こうした革新的なモデルをますます利用するようになっています。その結果、3D培養やオルガノイドのような複雑な系に合わせた細胞培養サプリメントの需要は大きく伸びると予想され、次世代生物医療研究と治療開発の重要な実現者としてのこのセグメントの地位が強化されます。

再生医療と幹細胞研究の急成長

再生医療と幹細胞研究セグメントの拡大は、世界の細胞培養サプリメント産業を後押しする主要な促進要因です。再生医療は、身体の治癒メカニズムを利用することで、損傷した組織や臓器を修復したり置き換えたりすることに重点を置いており、多くの場合、幹細胞を利用した治療法が用いられています。幹細胞は、自己複製と複数の細胞型への分化というユニークな能力を持っており、神経変性疾患、心血管障害、怪我を含む様々な症状の治療に貴重な存在となっています。例えば、2025年6月に『ニューイングランド・ジャーナル・オブ・メディシン』誌で報告された臨床検査では、1型糖尿病治療における大きな進歩が発表されました。その研究では、実験室で培養した膵島細胞を1回注入するだけで、患者が独立して十分なインスリンを産生できるようになることが実証されました。1年以内に、12人中10人がインスリンの補充を必要としなくなり、糖尿病管理のパラダイムシフトが起こる可能性が示されました。このデリケートな幹細胞を培養するには、多能性あるいは多能性を維持するための高度に特殊なサプリメントが必要です。これらのサプリメントは、必須栄養素、成長因子、サイトカイン、シグナル伝達分子などを供給し、細胞の増殖、生存、分化制御を促進します。

世界中で幹細胞治療の臨床検査が急増し、規制当局の承認も増えていることから、信頼性が高く拡大性のある細胞培養システムの需要が加速しています。組織工学と個別化医療のアプローチは、先進的サプリメントに支えられた最適化された細胞培養条件に大きく依存しています。サプリメントは新たな再生治療や幹細胞応用の成功と安全性を確保する上で重要な役割を果たすため、この動向は市場の力強い成長を維持すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞培養サプリメント市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助的な市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 細胞培養サプリメント市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 細胞培養サプリメント市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • 世界の細胞培養サプリメント市場の製品変動分析
  • 世界の細胞培養サプリメント市場規模と動向分析（製品別、2021～2033年）
  • 血清ベースサプリメント
  • タンパク質ベースと組み換えサプリメント
  • 化学定義サプリメント
  • その他

第5章 細胞培養サプリメント市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の細胞培養サプリメント市場の用途変動分析
  • 世界の細胞培養サプリメント市場規模と動向分析（用途別、2021～2033年）
  • バイオ医薬品製造
  • 細胞・遺伝子治療
  • 創薬
  • その他

第6章 細胞培養サプリメント市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 世界の細胞培養サプリメント市場の最終用途変動分析
  • 世界の細胞培養サプリメント市場規模と動向分析（最終用途別、2021～2033年）
  • 細胞培養培地メーカー
  • 製薬バイオテクノロジー企業
  • CDMO/CMOとCRO
  • 学術研究機関

第7章 細胞培養サプリメント市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2023年と2033年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2021～2033年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • HiMedia Laboratories
    • Danaher
    • Sartorius AG
    • Corning Inc.
    • R&D Systems（Bio-Techne）
    • STEMCELL Technologies
    • Repligen Corporation
    • Proteintech Group, Inc
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell culture supplements market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America cell culture supplements market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe cell culture supplements market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 25 UK cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 28 Germany cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 30 France cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 31 France cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific cell culture supplements market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 52 China cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 53 China cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 58 India cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 59 India cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America cell culture supplements market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA cell culture supplements market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 82 MEA cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE cell culture supplements market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait cell culture supplements market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait cell culture supplements market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait cell culture supplements market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cell culture supplements market: Market outlook
  • Fig. 5 Cell culture supplements market: Segment outlook
  • Fig. 6 Cell culture supplements market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cell culture supplements market driver impact
  • Fig. 9 Cell culture supplements market restraint impact
  • Fig. 10 Cell culture supplements market: Product outlook and key takeaways
  • Fig. 11 Cell culture supplements market: Product movement analysis
  • Fig. 12 Serum-Based Supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 Protein-Based & Recombinant Supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 Chemically defined supplements market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Cell culture supplements market: Application outlook and key takeaways
  • Fig. 17 Cell culture supplements market: Application movement analysis
  • Fig. 18 Biopharmaceutical manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Cell & gene therapy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Drug discovery market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Cell culture supplements market: End user outlook and key takeaways
  • Fig. 23 Cell culture supplements market: End user movement analysis
  • Fig. 24 Cell culture media manufacturers market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 25 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 CDMOs/ CMOs & CROs market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 27 Academic & research institutes market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 28 Global cell culture supplements market: Regional outlook and key takeaways
  • Fig. 29 Global cell culture supplements market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Key country dynamics
  • Fig. 32 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
目次
Product Code: GVR-4-68040-692-7

Cell Culture Supplements Market Summary

The global cell culture supplements market size was estimated at USD 2.53 billion in 2024 and is projected to reach USD 7.14 billion by 2033, growing at a CAGR of 12.74% from 2025 to 2033. This growth is driven by increasing demand for biopharmaceuticals, advancements in cell culture technology, and the rising focus on personalized medicine and regenerative therapies.

Advancements in 3D Cell Culture and Organoid Models

The growing adoption of 3D cell culture systems and organoid technologies significantly drives market demand for global cell culture supplements. Unlike conventional 2D cultures, 3D models accurately represent in vivo cellular environments, allowing researchers to study complex biological processes such as tissue development, cancer metastasis, and drug responses better. Organoids, in particular, have become vital tools in regenerative medicine and disease modeling, as they replicate the architecture and function of real human organs. For instance, a study published in Scientific Reports in July 2025 detailed the advancements in organoid-based models for infectious disease research. These 3D cell culture systems, derived from stem cells, offer more physiologically relevant human organ simulations than traditional 2D cultures. The study underscores the potential of organoid technology to accelerate drug discovery and reduce reliance on animal models. These advanced models require highly specific culture conditions and specialized supplements, including growth factors, extracellular matrix proteins, and defined media components to support cell differentiation, viability, and function.

Pharmaceutical companies, biotech firms, and academic institutions increasingly turn to these innovative models to improve drug discovery efficiency and reduce dependence on animal testing. As a result, the demand for cell culture supplements tailored to complex systems like 3D cultures and organoids is expected to grow significantly, reinforcing the segment's position as a critical enabler of next-generation biomedical research and therapeutic development.

Rapid Growth in Regenerative Medicine and Stem Cell Research

The expanding regenerative medicine and stem cell research field is a major driver boosting the global cell culture supplements industry. Regenerative medicine focuses on repairing or replacing damaged tissues and organs by harnessing the body's healing mechanisms, often through stem cell-based therapies. Stem cells possess the unique ability to self-renew and differentiate into multiple cell types, making them invaluable for treating various conditions, including neurodegenerative diseases, cardiovascular disorders, and injuries. For instance, a clinical trial reported in The New England Journal of Medicine in June 2025 announced a significant advancement in type 1 diabetes treatment. Their study demonstrated that a single infusion of lab-grown pancreatic islet cells enabled patients to produce sufficient insulin independently. Within a year, 10 out of 12 participants no longer required supplemental insulin, marking a potential paradigm shift in diabetes management. Culturing these delicate stem cells requires highly specialized supplements that maintain their pluripotency or multipotency. These supplements provide essential nutrients, growth factors, cytokines, and signaling molecules that promote cell proliferation, viability, and controlled differentiation.

The surge in clinical trials and increasing regulatory approvals of stem cell therapies worldwide are accelerating the demand for reliable and scalable cell culture systems. Tissue engineering and personalized medicine approaches rely heavily on optimized cell culture conditions supported by advanced supplements. This trend is expected to sustain strong growth in the market, as supplements play a crucial role in ensuring the success and safety of emerging regenerative treatments and stem cell applications.

Global Cell Culture Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell culture supplements market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Serum-based Supplements
  • Protein-based & Recombinant Supplements
  • Chemically Defined Supplements
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Drug Discovery
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Culture Media Manufacturers
  • Pharmaceutical & Biotechnology Companies
  • CDMOs/ CMOs & CROs
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Cell Culture Supplements Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in 3D cell culture and organoid models
      • 3.2.1.2. Rapid growth in regenerative medicine and stem cell research
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of GMP-grade and specialty supplements
      • 3.2.2.2. Regulatory and standardization challenges
  • 3.3. Cell Culture Supplements Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Cell Culture Supplements Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell Culture Supplements Market Product Movement Analysis
  • 4.3. Global Cell Culture Supplements Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Serum-Based Supplements
    • 4.4.1. Serum-Based Supplements market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Protein-Based & Recombinant Supplements
    • 4.5.1. Protein-Based & Recombinant Supplements market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Chemically Defined Supplements
    • 4.6.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Cell Culture Supplements Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell Culture Supplements Market Application Movement Analysis
  • 5.3. Global Cell Culture Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Biopharmaceutical Manufacturing
    • 5.4.1. Biopharmaceuticals manufacturing market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Cell & Gene Therapy
    • 5.5.1. Cell & gene therapy market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Discovery
    • 5.6.1. Drug discovery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Cell Culture Supplements Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cell Culture Supplements Market End Use Movement Analysis
  • 6.3. Global Cell Culture Supplements Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Cell Culture Media Manufacturers
    • 6.4.1. Cell culture media manufacturers companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Pharmaceuticals & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. CDMOs/ CMOs & CROs
    • 6.6.1. CDMOs/ CMOs & CROs market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Academic & Research Institutes
    • 6.7.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Cell Culture Supplements Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Competitive scenario
      • 7.4.1.3. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Merck KGaA
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product/Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Thermo Fisher Scientific Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product/Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. HiMedia Laboratories
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product/Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Danaher
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product/Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Sartorius AG
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product/Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Corning Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product/Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. R&D Systems (Bio-Techne)
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product/Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. STEMCELL Technologies
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product/Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Repligen Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product/Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Proteintech Group, Inc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product/Service benchmarking
      • 8.4.10.4. Strategic initiatives